Short Interest in cbdMD, Inc. (NYSEAMERICAN:YCBD) Declines By 39.1%

cbdMD, Inc. (NYSEAMERICAN:YCBD) was the recipient of a large decline in short interest in January. As of January 15th, there was short interest totaling 752,043 shares, a decline of 39.1% from the December 31st total of 1,234,477 shares. Currently, 7.3% of the company’s stock are short sold. Based on an average trading volume of 1,242,503 shares, the short-interest ratio is presently 0.6 days. Based on an average trading volume of 1,242,503 shares, the short-interest ratio is presently 0.6 days. Currently, 7.3% of the company’s stock are short sold.

Insider Activity at cbdMD

In related news, major shareholder Clark R. Crosnoe sold 550,701 shares of the business’s stock in a transaction on Wednesday, December 17th. The shares were sold at an average price of $2.32, for a total value of $1,277,626.32. Following the completion of the sale, the insider owned 17,875 shares of the company’s stock, valued at approximately $41,470. The trade was a 96.86% decrease in their position. The sale was disclosed in a legal filing with the Securities & Exchange Commission, which can be accessed through this hyperlink. 2.10% of the stock is owned by insiders.

cbdMD Stock Up 1.8%

NYSEAMERICAN:YCBD opened at $0.79 on Friday. cbdMD has a fifty-two week low of $0.47 and a fifty-two week high of $5.48. The firm’s 50 day moving average is $1.02 and its two-hundred day moving average is $0.92.

cbdMD Company Profile

cbdMD, Inc (NYSEAMERICAN: YCBD) is a Charlotte, North Carolina–based producer and distributor of hemp-derived cannabidiol (CBD) products. Since its founding in 2018, the company has focused on developing a diverse portfolio of wellness offerings designed for human and pet use. Its product range includes tinctures, capsules, gummies, topicals, and pet-specific formulations, each developed to comply with U.S. Food and Drug Administration (FDA) guidelines for hemp-derived substances.

The company operates a vertically integrated business model, sourcing U.S.-grown hemp and overseeing manufacturing processes in cGMP-certified facilities.